PARKINSON’S RESEARCH GRANTS FOR 2017
Parkinson’s NSW is calling for applications for Parkinson’s Research Grants up to the value of $50,000; and seed grants up to $20,000 each excl. GST, for biological/non-clinical and clinical/psychosocial research.
Grant Winners 2015- 2016
L to R: A/Prof Kay Double, A/Prof Simon Lewis, A/Prof Colleen Canning Dr Dan Johnstone, Dr Nicholas Dzamko, Dr Jin Sung Park
On April 11, Parkinson’s NSW hosted a morning tea at State Parliament to award over $288,000 in research grants to seven innovative projects. The Hon Victor Dominello MP, Minister for Innovation and Andrew Whitton, Parkinson’s NSW President presented the awards to the successful recipients.
The grant recipients include:
Dr James Macquarie Shine, Brain & Mind Research Institute, The University of Sydney A study of 100 people with Parkinson’s, using EEG to detect and predict the brain activation pattern that may allow for new treatments to be developed.
Dr Bryce Vissel, Garvan Institute, The University of New South Wales Research into the potential neuroprotective effect of UBP310 and investigate the role of KARs in a PD model.
A/Prof Colleen Canning, The University of Sydney A study to be conducted of 300 people with Parkinson’s to determine the attributes that most influence uptake and adherence of exercise programs.
A/Prof Kay Double, The University of Sydney Investigation into why Superoxide dismutase (SOD1) protein is aggregating in Parkinson’s disease and if the aggregation is concentrated in brain regions of cell loss.
Dr Dan Johnstone, The University of Sydney Research into three non-drug interventions – dietary saffron, near infrared light (NIr) and remote ischaemic conditioning in reducing the pathology and signs of Parkinson’s disease.
Dr Nicolas Dzamko, Neuroscience Research Australia, The University of New South Wales Research to determine if UPS35, a protein that regulates receptor trafficking and is genetically implicated in PD, contributes to the uptake of alpha-synucleins.
Dr Jin Sung-Park, Kolling Institute of Medical Research, The University of Sydney This project will attempt to provide a basis for developing therapies to treat mitochondrial dysfunction through identifying the proteins interacting with Nix (a selective autophagy receptor) during mitophagy.